السيرة الذاتية
PERSONAL INFORMATION
Name : Areej Ali Alzahrani
Nationality : Saudi
E-mail : alzahraniareej@yahoo.com
EDUCATION
Doctor of Philosophy, Molecular and Cellular Biology, Biological Sciences, University of Leeds, Leeds, United Kingdom 2017- 2022.
Master of Science, Bioscience, Biological Sciences, University of Leeds, Leeds, United Kingdom 2016 - 2017.
Bachelor of Science, Biochemistry, college of science, King Saud University, Riyadh, Saudi Arabia , 2007- 2011.
WORK EXPERIENCE
Assistant professor, Biochemistry department, college of science, King Saud University, 2023 - present
Demonstrator, Biochemistry department, college of science, King Saud University, 2014 – 2023.
Research Technician, Translational Cancer Research, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Centrer
2012 – 2014.
LABORATORY SKILLS
- Mammalian cell culture
- Transfection and Transduction
- Immunofluorescence technique
- Light microscopy, fluorescence microscopy
- Data Analysis
- Western blotting
- DNA and protein extraction
- PCR techniques
- Gene cloning
- Bacterial transformation and mini prep
PUBLICATIONS
Alonazi, M.; Krayem, N.; Alzahrani, A.A.; Horchani, H.; Ben Bacha, A. Novel Phospholipase C with High Catalytic Activity from a Bacillus stearothermophilus Strain: An Ideal Choice for the Oil Degumming Process. Processes 2023, 11, 3310. https://doi.org/10.3390/pr11123310
Divan, A, Alzahrani, A, Shaik, F, Mitchell, J, Harrison, MA, Odell, A, et al. A research-led flexible cell biology practical for biological sciences undergraduate and postgraduate degree courses. Biochem Mol Biol Educ. 2023; 51(4): 394–401.
Saikia Q, Reeve H, Alzahrani A, Critchley WR, Zeqiraj E, Divan A, Harrison MA, Ponnambalam S (2023) VEGFR endocytosis: implications for angiogenesis. Prog Mol Biol Transl Sci. 194:109-139. doi: 10.1016/bs.pmbts.2022.06.021.
Jade D, Alzahrani A, Critchley W, Ponnambalam S, Harrison MA. (2022) Identification of FDA-approved drugs against SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) through computational virtual screening. Struct Chem. 1-15. doi: 10.1007/s11224-022-02072-1. Epub ahead of print.
Alhuqail, A. J., Alzahrani, A., Almubarak, H., Al-Qadheeb, S., Alghofaili, L., Almoghrabi, N., ... & Karakas, B. (2018). High prevalence of deleterious BRCA1 and BRCA2 germline mutations in Arab breast and ovarian cancer patients. Breast cancer research and treatment, 168, 695-702.
CONFERENCES
Alzahrani A, Harrison M, Zeqiraj E, Ponnambalam S 'Genome-wide screening of deubiquitinases in VEGFR2' BSDB/BSCB Joint Spring Meeting, Warwick, UK, 3-6 April 2022. (Poster).
Alzahrani A, Harrison M, Zeqiraj E, Ponnambalam S ‘A cell-based screen for deubiquitinase regulation of angiogenesis' ‘Cell La Vie’ joint BSCB-SNCF meeting between UK and France cell biology societies, September 2021. (Poster).
Alzahrani A, Harrison M, Zeqiraj E, Ponnambalam S 'A reverse genetics-based deubiquitinase (DUB) screen for VEGF receptor tyrosine kinase stability and turnover' American Society for Cell Biology (ASCB) and the European Molecular Biology Organization (EMBO) Meeting, December 2020. (Poster).